InvestorsHub Logo
Followers 862
Posts 28265
Boards Moderated 1
Alias Born 03/16/2014

Re: None

Wednesday, 11/06/2019 12:38:41 PM

Wednesday, November 06, 2019 12:38:41 PM

Post# of 30387
FDA ENFORCEMENT DISCRETION FOR PURE CBD PRODUCTS ONLY

As the only publicly traded company in America growing and processing hemp for CBD Isolate and selling a full lineup of Pure CBD Oil products using terpenes to create the entourage effect, CANB is best positioned to deliver a windfall to its investors due to the FDA permitting the national sales of Pure CBD products only

Mile High Labs and Medterra are two of the biggest CBD Isolate processors and Pure CBD Oil products companies in America and both are wildly successful, but neither one is publicly traded, so where else can an investor gain exposure to a fully vertically integrated Pure CBD Oil product company besides CANB?


This is why CANB is a great stock to own before the FDA announces Enforcement Discretion for Pure CBD products

Here is a closer look at what Enforcement Discretion for Pure CBD products would mean for these products:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=152094460


Now getting back to the question of CBD formulation and the difference between Pure CBD products, Full Spectrum CBD products and Broad Spectrum CBD products

When people say “CBD” and think about OTC products, there are 3 possible options that come to mind in terms of formulation

Before we talk about the different formulations, please understand that Hemp contains many different cannabinoids

Some say 50, others say 75, 100 or even 150+

We are only going to talk about the top 5 cannabinoids that show up in laboratory tests of hemp:

CBD

THC

CBG/CBN/CBC



Now, getting back to the most important topic of all — CBD formulations

A company has 3 basic options when it manufactures products containing CBD

1ST OPTION: “PURE CBD” OR “CBD ISOLATE”

1 CANNABINOID


CBD is CBD, right

It is often referred to as CBD Isolate

Isolate meaning the CBD is isolated from the other cannabinoids

There is Pure CBD and nothing else

A variety of different oils and fluids are typically used as solvents

Terpenes are federally legal and can be utilized to create the entourage effect


2ND OPTION: “FULL SPECTRUM CBD” OR “FULL SPECTRUM HEMP EXTRACT”

5 CANNABINOIDS


This is CBD + THC + CBG/CBN/CBC

There is no isolation or purification of the CBD here

CBD exists in its native form alongside 4 other cannabinoids (there are many more cannabinoids actually present, these are just the top 5 by concentration)

A variety of different oils and fluids are typically used as solvents


3RD OPTION: “BROAD SPECTRUM CBD”

4 CANNABINOIDS


This is CBD + CBG/CBN/CBC

The THC has been removed

In order to make this formulation, CBD is first isolated from everything else

After the THC has been removed, the CBD Isolate is then mixed back in with CBG/CBN/CBC

A variety of different oils and fluids are typically used as solvents


With this background information in mind, please feel free to read why I believe the FDA will choose Pure CBD (CBD Isolate) as the first CBD formulation to obtain federal permission to be placed into the food supply and dietary supplements, published on July 25th:

AN FDA-CENTRIC CANNABINOID-BASED PARADIGM FOR CBD PRODUCT REGULATION

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150123700


Hard evidence supporting this Pure CBD thesis began pouring in shortly thereafter

5 days after I published my framework, on July 30th Dr. Gottlieb wrote a piece in the Washington Post which strongly suggested that Purified CBD will become the 1st CBD formulation permitted by the FDA:

PROOF THAT THE FDA WILL APPROVE CANB’S CBD OIL PRODUCTS

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150292900


On August 9th, Dr. Gottlieb appeared on CNBC and added to the evidence that Pure CBD will receive the green light from the FDA:

CNBC VIDEO: PURIFIED CBD WILL BE FEDERALLY PERMITTED BY FDA

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150438663


If you only have 15 seconds of time, watch Dr. Gottlieb rule out THC in CBD products right here:




On August 7th, Dr. Gottlieb appeared on C-SPAN and spoke about the timeframe for Pure CBD to be given the FDA’s blessing as “Immediate” — here’s a 90 second clip:

“IMMEDIATE” FDA APPROVAL FOR PURE CBD IN THE FOOD SUPPLY AND DIETARY SUPPLEMENTS


https://www.c-span.org/video/?c4813527/user-clip-dr-gottlieb-the-fda-approve-cbd-isolate-immediately


On 9/12/19 during a quarterly conference call, Aurora Cannabis CEO Terry Booth predicted the FDA will choose CBD Isolate as the first formulation to attain approval for national sales:

AURORA CEO PREDICTS FDA WILL CHOOSE CBD ISOLATE

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151289189


As the only publicly traded company in America growing and processing hemp for CBD Isolate and selling a full lineup of Pure CBD Oil products using terpenes to create the entourage effect, CANB is best positioned to deliver a windfall to its investors due to the FDA permitting the national sales of Pure CBD products only

Mile High Labs and Medterra are two of the biggest CBD Isolate processors and Pure CBD Oil products companies in America and both are wildly successful, but neither one is publicly traded, so where else can an investor gain exposure to a fully vertically integrated Pure CBD Oil product company besides CANB?


Sleek
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CANB News